[CME. Biologics in vasculitis].

Suppr

超能文献

作者信息

Scharl Michael, Schaer Dominik, Vallelian Florence

机构信息

Klinik und Poliklinik für Innere Medizin, Universitätsspital Zürich.

出版信息

Praxis (Bern 1994). 2015 Jan 2;104(1):7-16; quiz 15. doi: 10.1024/1661-8157/a001876.

DOI:10.1024/1661-8157/a001876

PMID:25552441

Abstract

摘要

相似文献

[CME. Biologics in vasculitis].

Praxis (Bern 1994). 2015 Jan 2;104(1):7-16; quiz 15. doi: 10.1024/1661-8157/a001876.

[Vasculitis: update 2014].

Dtsch Med Wochenschr. 2014 Jun;139(23):1234-6. doi: 10.1055/s-0034-1370063. Epub 2014 May 27.

Safety issues of biologics in pregnant patients with rheumatic diseases.

Ann N Y Acad Sci. 2014 May;1317:32-8. doi: 10.1111/nyas.12456. Epub 2014 May 19.

L6. Eosinophilic granulomatosis with polyangiitis: future therapies.

Presse Med. 2013 Apr;42(4 Pt 2):510-2. doi: 10.1016/j.lpm.2013.01.006. Epub 2013 Feb 28.

Biological therapies: new treatment options for ANCA-associated vasculitis?

Expert Opin Biol Ther. 2007 Apr;7(4):521-33. doi: 10.1517/14712598.7.4.521.

The efficacy and tolerability of newer biologics in rheumatoid arthritis: best current evidence.

Curr Opin Rheumatol. 2007 May;19(3):308-13. doi: 10.1097/01.bor.0000265447.48722.04.

[A case of Churg-Strauss syndrome with short duration from the onset of asthma to diagnosis of vasculitis].

Nihon Jinzo Gakkai Shi. 2013;55(1):71-6.

Refractory warm IgM-mediated autoimmune hemolytic anemia associated with Churg-Strauss syndrome responsive to eculizumab and rituximab.

Am J Hematol. 2015 Jan;90(1):78-81. doi: 10.1002/ajh.23791. Epub 2014 Jul 11.

Role of omalizumab and steroids in Churg-Strauss syndrome.

J Allergy Clin Immunol. 2009 Sep;124(3):600-1. doi: 10.1016/j.jaci.2009.05.023. Epub 2009 Jul 24.

Biological therapy for systemic vasculitis: a systematic review.

Semin Arthritis Rheum. 2014 Feb;43(4):542-57. doi: 10.1016/j.semarthrit.2013.07.010. Epub 2013 Aug 24.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

[CME. Biologics in vasculitis].

Praxis (Bern 1994). 2015 Jan 2;104(1):7-16; quiz 15. doi: 10.1024/1661-8157/a001876.

[Vasculitis: update 2014].

Dtsch Med Wochenschr. 2014 Jun;139(23):1234-6. doi: 10.1055/s-0034-1370063. Epub 2014 May 27.

Safety issues of biologics in pregnant patients with rheumatic diseases.

Ann N Y Acad Sci. 2014 May;1317:32-8. doi: 10.1111/nyas.12456. Epub 2014 May 19.

L6. Eosinophilic granulomatosis with polyangiitis: future therapies.

Presse Med. 2013 Apr;42(4 Pt 2):510-2. doi: 10.1016/j.lpm.2013.01.006. Epub 2013 Feb 28.

Biological therapies: new treatment options for ANCA-associated vasculitis?

Expert Opin Biol Ther. 2007 Apr;7(4):521-33. doi: 10.1517/14712598.7.4.521.

The efficacy and tolerability of newer biologics in rheumatoid arthritis: best current evidence.

Curr Opin Rheumatol. 2007 May;19(3):308-13. doi: 10.1097/01.bor.0000265447.48722.04.

[A case of Churg-Strauss syndrome with short duration from the onset of asthma to diagnosis of vasculitis].

Nihon Jinzo Gakkai Shi. 2013;55(1):71-6.

Refractory warm IgM-mediated autoimmune hemolytic anemia associated with Churg-Strauss syndrome responsive to eculizumab and rituximab.

Am J Hematol. 2015 Jan;90(1):78-81. doi: 10.1002/ajh.23791. Epub 2014 Jul 11.

Role of omalizumab and steroids in Churg-Strauss syndrome.

J Allergy Clin Immunol. 2009 Sep;124(3):600-1. doi: 10.1016/j.jaci.2009.05.023. Epub 2009 Jul 24.

Biological therapy for systemic vasculitis: a systematic review.

Semin Arthritis Rheum. 2014 Feb;43(4):542-57. doi: 10.1016/j.semarthrit.2013.07.010. Epub 2013 Aug 24.